[Answered] Which is NOT a component of an optimization model? a.constraints b.objective function c.decision ...

This topic contains a solution. Click here to go to the answer

Author Question: Which is NOT a component of an optimization model? a.constraints b.objective function c.decision ... (Read 205 times)

kellyjaisingh

Hero Member
Posts: 540

on: Aug 1, 2018

Which is NOT a component of an optimization model?
a.constraints
b.objective function
c.decision variables
d.descriptive function

Question 2

The term operations research was coined during:
a.the Gulf War.
b.WWII.
c.the Great Depression.
d.WWI.

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

recede

Sr. Member
Posts: 315

Reply #1 on: Aug 1, 2018

Answer to Question 1

correct: d

Answer to Question 2

correct: b

kellyjaisingh

Member
Posts: 540

Reply 2 on: Aug 1, 2018

YES! Correct, THANKS for helping me on my review

xiaomengxian

Member
Posts: 311

Reply 3 on: Yesterday

Great answer, keep it coming

« previous next »

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

Adolescents often feel clumsy during puberty because during this time of development, their hands and feet grow faster than their arms and legs do. The body is therefore out of proportion. One out of five adolescents actually experiences growing pains during this period.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

It is believed that the Incas used anesthesia. Evidence supports the theory that shamans chewed cocoa leaves and drilled holes into the heads of patients (letting evil spirits escape), spitting into the wounds they made. The mixture of cocaine, saliva, and resin numbed the site enough to allow hours of drilling.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.